Cannformatics e phatlalalitse hore e khethile li-biomarker tse ncha tse 22 tsa lipid-based Cannabis-Responsive™ matheng a bana ba nang le autism spectrum disorder (ASD). Li-biomarker tsohle tse 22 li fetohetse ho mofuta oa fisioloji oa bana ba ntseng ba hola kamora kalafo e atlehileng ea cannabis. Li-biomarker tsena li kenyelletsa li-lipids tsa tsamaiso ea methapo e amanang haholo le ts'ebetso ea cellular bokong e bonts'ang bokhoni ba cannabis ba bongaka ba ho ama tšebetso ea neuron ho bana ba ASD. Lintho tsena tse sibollotsoeng li tsoela pele ka tsoelo-pele ea k'hamphani ea ho qala ts'ebeletso ea meriana ea motho ka mong e le sesebelisoa ho bafani ba tlhokomelo ea bophelo le bakuli ba batlang ho sebelisa meriana le lihlahisoa tse thehiloeng ho cannabinoid ho phekola maemo a thata a bongaka.
Khamphani e phatlalalitse liphuputso tsa eona koranteng ea Cannabis le Patlisiso ea Cannabinoid pampiring e nang le sehlooho se reng, "Monyetla oa li-biomarker tse arabelang ka lipid-based cannabis ho lekola kalafo ea cannabis ea bongaka ho bana ba ASD." Pampiri ena ke pampiri ea bobeli ho tsoa boithutong ba khamphani ba ASD Pilot. Pampiri ea pele e phatlalalitsoeng ka December 2021 e thehile li-biomarker tse arabelang ka Cannabis e le sesebelisoa sa lefats'e sa ho lekanya phello ea cannabis ea bongaka. Ka kopanelo lipampiri tsena tse peli li bonts'a monyetla oa hore li-biomarker tse arabelang ka mathe e be sesebelisoa bakeng sa baoki ka bobeli ba phekolang bakuli ka cannabis ea bongaka le lik'hamphani tsa mahlale a bophelo tse hlahisang meriana le lits'ebetso tse thehiloeng molokong o tlang.
"Ka ho notlolla mokhoa oa ts'ebetso oa cannabis ea bongaka, re bonts'a hore li-biomarker tse arabelang ka Cannabis li ka fa lik'hamphani tsa mahlale a bophelo le lingaka lisebelisoa tse ncha tsa ho utloisisa karolo ea cannabis ho boloka homeostasis ea tsamaiso ea methapo e bohareng ho bana ba ASD. Boithuto bona bo boetse bo bula menyetla e mecha ea ho lekola kalafo ea cannabis ea bongaka mafung a neurodegenerative joalo ka lefu la Alzheimer's, lefu la Parkinson le ALS, moo tse ling tsa li-biomarker tse arabelang ka lipid-based Cannabis-Responsive lipids li tsejoang hore li bapala karolo ", ho boletse Itzhak Kurek, PhD. , CEO le mothehi-mmoho oa Cannformatics. "Hona joale re boemong ba ho phahamisa chelete e hlokahalang ho qala sethala sa litšebeletso tsa ASD le ho hola ho ba mafu a neurodegenerative."
"Ho phatlalatsoa ha pampiri ena ea bobeli ke nako ea bohlokoa ho Cannformatics kaha e tiisa theknoloji ea rona ka botlalo 'me e re beha ka ho hlaka re le moetapele oa biotechnology kalafong ea cannabis ea bongaka," ho boletse Kenneth Epstein Chief Commercial Officer le mothehi-moho oa Cannformatics. “Re tsoela pele ho leboha bana le malapa a kentseng letsoho thutong ena hammoho le batšehetsi ba rona Canniatric and Whole Plant Access for Autism. Liphuputso tsa phuputso ena li ile tsa feta kamoo re neng re lebeletse kateng.”
